Taiwan · Delayed Price · Currency is TWD Onyx Healthcare Statistics
Total Valuation
Onyx Healthcare has a market cap or net worth of TWD 3.93 billion. The enterprise value is 3.99 billion.
| Market Cap | 3.93B |
| Enterprise Value | 3.99B |
Important Dates
The next estimated earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | Jul 3, 2025 |
Share Statistics
Onyx Healthcare has 39.07 million shares outstanding. The number of shares has increased by 1.37% in one year.
| Current Share Class | 39.07M |
| Shares Outstanding | 39.07M |
| Shares Change (YoY) | +1.37% |
| Shares Change (QoQ) | +2.34% |
| Owned by Insiders (%) | 12.04% |
| Owned by Institutions (%) | 0.02% |
| Float | 12.30M |
Valuation Ratios
The trailing PE ratio is 27.32.
| PE Ratio | 27.32 |
| Forward PE | n/a |
| PS Ratio | 2.84 |
| PB Ratio | 2.45 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | 163.31 |
| P/OCF Ratio | 102.80 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.68, with an EV/FCF ratio of 166.12.
| EV / Earnings | 27.54 |
| EV / Sales | 2.89 |
| EV / EBITDA | 22.68 |
| EV / EBIT | 25.67 |
| EV / FCF | 166.12 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.20.
| Current Ratio | 1.84 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 2.82 |
| Debt / FCF | 13.05 |
| Interest Coverage | 18.05 |
Financial Efficiency
Return on equity (ROE) is 9.02% and return on invested capital (ROIC) is 5.02%.
| Return on Equity (ROE) | 9.02% |
| Return on Assets (ROA) | 2.59% |
| Return on Invested Capital (ROIC) | 5.02% |
| Return on Capital Employed (ROCE) | 5.05% |
| Weighted Average Cost of Capital (WACC) | 5.45% |
| Revenue Per Employee | 11.51M |
| Profits Per Employee | 1.21M |
| Employee Count | 120 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 2.85 |
Taxes
In the past 12 months, Onyx Healthcare has paid 21.52 million in taxes.
| Income Tax | 21.52M |
| Effective Tax Rate | 12.95% |
Stock Price Statistics
The stock price has decreased by -20.87% in the last 52 weeks. The beta is 0.28, so Onyx Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -20.87% |
| 50-Day Moving Average | 97.63 |
| 200-Day Moving Average | 111.28 |
| Relative Strength Index (RSI) | 51.03 |
| Average Volume (20 Days) | 67,191 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onyx Healthcare had revenue of TWD 1.38 billion and earned 145.04 million in profits. Earnings per share was 3.68.
| Revenue | 1.38B |
| Gross Profit | 477.85M |
| Operating Income | 90.79M |
| Pretax Income | 166.16M |
| Net Income | 145.04M |
| EBITDA | 106.36M |
| EBIT | 90.79M |
| Earnings Per Share (EPS) | 3.68 |
Balance Sheet
The company has 246.08 million in cash and 313.78 million in debt, with a net cash position of -67.71 million or -1.73 per share.
| Cash & Cash Equivalents | 246.08M |
| Total Debt | 313.78M |
| Net Cash | -67.71M |
| Net Cash Per Share | -1.73 |
| Equity (Book Value) | 1.60B |
| Book Value Per Share | 39.75 |
| Working Capital | 402.03M |
Cash Flow
In the last 12 months, operating cash flow was 38.20 million and capital expenditures -14.15 million, giving a free cash flow of 24.04 million.
| Operating Cash Flow | 38.20M |
| Capital Expenditures | -14.15M |
| Depreciation & Amortization | 15.57M |
| Net Borrowing | 132.75M |
| Free Cash Flow | 24.04M |
| FCF Per Share | 0.62 |
Margins
Gross margin is 34.61%, with operating and profit margins of 6.58% and 10.50%.
| Gross Margin | 34.61% |
| Operating Margin | 6.58% |
| Pretax Margin | 12.03% |
| Profit Margin | 10.50% |
| EBITDA Margin | 7.70% |
| EBIT Margin | 6.58% |
| FCF Margin | 1.74% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 2.49%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 2.49% |
| Dividend Growth (YoY) | -20.74% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 106.54% |
| Buyback Yield | -1.37% |
| Shareholder Yield | 1.12% |
| Earnings Yield | 3.69% |
| FCF Yield | 0.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 1, 2024. It was a forward split with a ratio of 1.1499016.
| Last Split Date | Aug 1, 2024 |
| Split Type | Forward |
| Split Ratio | 1.1499016 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |